These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15608674)

  • 21. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
    Yoon SJ; Park I; Kwak C; Lee E
    Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
    Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
    Wang Y; Chen W; Yang C; Wu W; Wu S; Qin X; Li X
    Int J Oncol; 2012 Jul; 41(1):276-84. PubMed ID: 22576688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line.
    Yatomi M; Takiguchi Y; Asaka-Amano Y; Arai M; Tada Y; Kurosu K; Sakao S; Kasahara Y; Tanabe N; Tatsumi K; Seki N; Kuriyama T
    Anticancer Res; 2007; 27(5A):3235-43. PubMed ID: 17970066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
    Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
    Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
    Lee S; Yoon CY; Byun SS; Lee E; Lee SE
    J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells.
    Afroze T; Sadi AM; Momen MA; Gu S; Heximer S; Husain M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1305-11. PubMed ID: 17363689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.
    Kashiwagi E; Izumi H; Yasuniwa Y; Baba R; Doi Y; Kidani A; Arao T; Nishio K; Naito S; Kohno K
    Cancer Sci; 2011 Feb; 102(2):382-6. PubMed ID: 21087353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
    Cimbora-Zovko T; Fritz G; Mikac N; Osmak M
    Cancer Lett; 2010 Sep; 295(2):182-90. PubMed ID: 20303648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
    Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
    Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.
    Xu H; Choi SM; An CS; Min YD; Kim KC; Kim KJ; Choi CH
    Biochem Biophys Res Commun; 2005 Mar; 328(2):618-22. PubMed ID: 15694393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.
    Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP
    Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
    Shang XB; Yu ZT; Tang P; Zhang XZ
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2799-802. PubMed ID: 19080461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
    Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
    Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
    Lai MD; Lin WC; Sun YM; Chang FL
    Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.